Clinical Trial Update: Efficacy and Safety of Oltipraz for Liver Fat Reduction in Patients With Non-Alcoholic Fatty Liver Disease Except for Liver Cirrhosis [Phase 3]

View source ↗

Summary

This clinical trial update reports on the efficacy and safety of oltipraz for reducing liver fat in adults with non-alcoholic fatty liver disease (excluding liv…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease

Drugs mentioned

• Oltipraz (oltipraz)

Snippet

Sponsor: PharmaKing | Conditions: Non-alcholic Fatty Liver Disease | Phase 3 | Status: COMPLETED